Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy
Condition(s):Non-proliferative Diabetic RetinopathyLast Updated:December 8, 2023Active, not recruiting